"Biological Assay" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A method of measuring the effects of a biologically active substance using an intermediate in vivo or in vitro tissue or cell model under controlled conditions. It includes virulence studies in animal fetuses in utero, mouse convulsion bioassay of insulin, quantitation of tumor-initiator systems in mouse skin, calculation of potentiating effects of a hormonal factor in an isolated strip of contracting stomach muscle, etc.
| Descriptor ID |
D001681
|
| MeSH Number(s) |
E05.091
|
| Concept/Terms |
Biological Assay- Biological Assay
- Assay, Biological
- Biological Assays
- Biologic Assays
- Biologic Assay
- Assay, Biologic
- Assays, Biologic
- Bioassay
- Bioassays
- Assays, Biological
|
Below are MeSH descriptors whose meaning is more general than "Biological Assay".
Below are MeSH descriptors whose meaning is more specific than "Biological Assay".
This graph shows the total number of publications written about "Biological Assay" by people in this website by year, and whether "Biological Assay" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2011 | 2 | 1 | 3 |
| 2013 | 0 | 2 | 2 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 0 | 2 | 2 |
| 2017 | 11 | 12 | 23 |
| 2018 | 9 | 13 | 22 |
| 2019 | 3 | 2 | 5 |
| 2020 | 3 | 6 | 9 |
| 2021 | 2 | 3 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Biological Assay" by people in Profiles.
-
A dried blood spot protocol for high throughput analysis of SARS-CoV-2 serology based on the Roche Elecsys anti-N assay. EBioMedicine. 2021 Aug; 70:103502.
-
How the COVID-19 pandemic is changing clinical trial conduct and driving innovation in bioanalysis. Bioanalysis. 2021 Aug; 13(15):1195-1203.
-
Lessons learned from the COVID-19 pandemic and its impact on bioanalysis and drug development. Bioanalysis. 2021 Aug; 13(15):1205-1211.
-
Performance of 4 Automated SARS-CoV-2 Serology Assay Platforms in a Large Cohort Including Susceptible COVID-19-Negative and COVID-19-Positive Patients. J Appl Lab Med. 2021 07 07; 6(4):942-952.
-
Rapid, reliable, and reproducible cell fusion assay to quantify SARS-Cov-2 spike interaction with hACE2. PLoS Pathog. 2021 06; 17(6):e1009683.
-
Disposable photonics for cost-effective clinical bioassays: application to COVID-19 antibody testing. Lab Chip. 2021 08 07; 21(15):2913-2921.
-
Development and Validation of a Method for Quantification of Favipiravir as COVID-19 Management in Spiked Human Plasma. Molecules. 2021 Jun 22; 26(13).
-
Efficiency Improvements and Discovery of New Substrates for a SARS-CoV-2 Main Protease FRET Assay. SLAS Discov. 2021 10; 26(9):1189-1199.
-
Validation of high-throughput, semiquantitative solid-phase SARS coronavirus-2 serology assays in serum and dried blood spot matrices. Bioanalysis. 2021 Aug; 13(15):1183-1193.
-
Simple rapid in vitro screening method for SARS-CoV-2 anti-virals that identifies potential cytomorbidity-associated false positives. Virol J. 2021 06 09; 18(1):123.